Hodowanec AC - Search Results

1

Imlay H, Hodowanec AC, Komatsu TE, O'Rear J, Pikis A, Limaye AP. Imlay H, et al. Among authors: hodowanec ac. Clin Infect Dis. 2022 Nov 30;75(11):2047-2048. doi: 10.1093/cid/ciac678. Clin Infect Dis. 2022. PMID: 35993127 No abstract available.

2

Treatment and Prevention of CMV Disease in Transplant Recipients: Current Knowledge and Future Perspectives.

Hodowanec AC, Pikis A, Komatsu TE, Sampson MR, Younis IR, O'Rear JJ, Singer ME. Hodowanec AC, et al. J Clin Pharmacol. 2019 Jun;59(6):784-798. doi: 10.1002/jcph.1363. Epub 2018 Dec 26. J Clin Pharmacol. 2019. PMID: 30586161 Review.

3

In-depth genomic analyses identified novel letermovir resistance-associated substitutions in the cytomegalovirus UL56 and UL89 gene products.

Komatsu TE, Hodowanec AC, Colberg-Poley AM, Pikis A, Singer ME, O'Rear JJ, Donaldson EF. Komatsu TE, et al. Among authors: hodowanec ac. Antiviral Res. 2019 Sep;169:104549. doi: 10.1016/j.antiviral.2019.104549. Epub 2019 Jul 4. Antiviral Res. 2019. PMID: 31279814 Clinical Trial.

4

The Development of Therapeutics for the Treatment and Prevention of CMV Disease in the Transplant Population: A Regulatory Perspective.

Hodowanec AC, Pikis A, Singer ME. Hodowanec AC, et al. J Infect Dis. 2020 Mar 5;221(Suppl 1):S109-S112. doi: 10.1093/infdis/jiz389. J Infect Dis. 2020. PMID: 32134476 Free PMC article. Review.

5

Consensus Definitions of BK Polyomavirus Nephropathy in Renal Transplant Recipients for Clinical Trials.

Imlay H, Baum P, Brennan DC, Hanson KE, Hodges MR, Hodowanec AC, Komatsu TE, Ljungman P, Miller V, Natori Y, Nickeleit V, O'Rear J, Pikis A, Randhawa PS, Sawinski D, Singh HK, Westman G, Limaye AP. Imlay H, et al. Among authors: hodowanec ac. Clin Infect Dis. 2022 Sep 30;75(7):1210-1216. doi: 10.1093/cid/ciac071. Clin Infect Dis. 2022. PMID: 35100619 Free PMC article.

6

Long-Acting Formulations for the Prevention and Treatment of Human Immunodeficiency Virus (HIV)-1 Infection: Strategic Leveraging and Integration of Multidisciplinary Knowledge to Advance Public Health.

Arya V, Hodowanec AC, Troy SB, Struble KA. Arya V, et al. Among authors: hodowanec ac. Clin Infect Dis. 2022 Nov 21;75(Suppl 4):S498-S501. doi: 10.1093/cid/ciac671. Clin Infect Dis. 2022. PMID: 36410378

7

Drug Development 101: A Primer.

Buckley LA, Bebenek I, Cornwell PD, Hodowanec A, Jensen EC, Murphy C, Ghantous HN. Buckley LA, et al. Int J Toxicol. 2020 Sep/Oct;39(5):379-396. doi: 10.1177/1091581820939083. Epub 2020 Aug 7. Int J Toxicol. 2020. PMID: 32762387

8

Late primary cytomegalovirus infection presenting with acute inflammatory demyelinating polyneuropathy in a heart transplant recipient: a case report and review of the literature.

Hodowanec AC, Simon DM. Hodowanec AC, et al. Transpl Infect Dis. 2012 Oct;14(5):E116-20. doi: 10.1111/tid.12000. Epub 2012 Sep 2. Transpl Infect Dis. 2012. PMID: 22938143 Review.

9

Extended Low-Dose Valganciclovir Is Effective Prophylaxis Against Cytomegalovirus in High-Risk Kidney Transplant Recipients With Near-Complete Eradication of Late-Onset Disease.

Fayek SA, Beshears E, Lieber R, Alvey N, Sauer A, Poirier J, Hollinger EF, Olaitan OK, Jensik S, Geyston J, Brokhof MM, Hodowanec AC, Hertl M, Simon DM. Fayek SA, et al. Among authors: hodowanec ac. Transplant Proc. 2016 Jul-Aug;48(6):2056-2064.e1. doi: 10.1016/j.transproceed.2016.05.004. Transplant Proc. 2016. PMID: 27569944

10

BK virus screening and management practices among US renal transplant programs: a survey.

Hodowanec AC, Simon DM. Hodowanec AC, et al. Transpl Int. 2015 Nov;28(11):1339-41. doi: 10.1111/tri.12602. Epub 2015 May 21. Transpl Int. 2015. PMID: 25959495 Free article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

19 results

Search Page

Filters